Supernus Pharmaceuticals | Beneficio Operativo



Operating Profit Cambio Fecha
Abbott USD 2.07B 415M 2025-06
ANI Pharmaceuticals USD 15.17M 11.02M 2025-06
Aurora Cannabis CAD 36.22M 38.61M 2024-12
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 26.67M 23.26M 2025-06
Eisai JPY 20.74B 21.77B 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
Novo Nordisk 34.08B 4.71B 2025-06
Pacira USD 10.23M 8.24M 2025-06
Perrigo USD 55.6M 23.8M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Supernus Pharmaceuticals USD 12.14M 14.74M 2025-06
United Therapeutics USD 276.9M 105.9M 2025-06
Xeris Pharmaceuticals USD 1.68M 14.57M 2024-12


Supernus Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.